Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The use of a reversible proteasome inhibitor in a model of Reduced-Size Orthotopic Liver transplantation in rats.

Padrissa-Altés S, Zaouali MA, Boncompagni E, Bonaccorsi-Riani E, Carbonell T, Bardag-Gorce F, Oliva J, French SW, Bartrons R, Roselló-Catafau J.

Exp Mol Pathol. 2012 Aug;93(1):99-110. doi: 10.1016/j.yexmp.2012.03.011. Epub 2012 Mar 25.

PMID:
22475623
2.

Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury.

Zaouali MA, Bardag-Gorce F, Carbonell T, Oliva J, Pantazi E, Bejaoui M, Ben Abdennebi H, Rimola A, Roselló-Catafau J.

Exp Mol Pathol. 2013 Apr;94(2):352-9. doi: 10.1016/j.yexmp.2012.12.005. Epub 2013 Jan 7.

PMID:
23305864
3.

How ischaemic preconditioning protects small liver grafts.

Franco-Gou R, Roselló-Catafau J, Casillas-Ramirez A, Massip-Salcedo M, Rimola A, Calvo N, Bartrons R, Peralta C.

J Pathol. 2006 Jan;208(1):62-73.

PMID:
16261637
4.

Sirtuin 1 in rat orthotopic liver transplantation: an IGL-1 preservation solution approach.

Pantazi E, Zaouali MA, Bejaoui M, Folch-Puy E, Ben Abdennebi H, Varela AT, Rolo AP, Palmeira CM, Roselló-Catafau J.

World J Gastroenterol. 2015 Feb 14;21(6):1765-74. doi: 10.3748/wjg.v21.i6.1765.

5.

Effects of Institut Georges Lopez-1 and Celsior preservation solutions on liver graft injury.

Tabka D, Bejaoui M, Javellaud J, Roselló-Catafau J, Achard JM, Abdennebi HB.

World J Gastroenterol. 2015 Apr 14;21(14):4159-68. doi: 10.3748/wjg.v21.i14.4159.

6.
7.

The protective effects of the proteasome inhibitor bortezomib (velcade) on ischemia-reperfusion injury in the rat retina.

Chen FT, Yang CM, Yang CH.

PLoS One. 2013 May 14;8(5):e64262. doi: 10.1371/journal.pone.0064262. Print 2013.

8.

Proteasome inhibitor attenuates skeletal muscle reperfusion injury by blocking the pathway of nuclear factor-kappaB activation.

Park JW, Qi WN, Cai Y, Urbaniak JR, Chen LE.

Plast Reconstr Surg. 2007 Dec;120(7):1808-18.

PMID:
18090742
9.

Ischemia-reperfusion injury in rat steatotic liver is dependent on NFκB P65 activation.

Ramachandran S, Liaw JM, Jia J, Glasgow SC, Liu W, Csontos K, Upadhya GA, Mohanakumar T, Chapman WC.

Transpl Immunol. 2012 Jun;26(4):201-6. doi: 10.1016/j.trim.2012.01.001. Epub 2012 Jan 21.

10.

AMPK involvement in endoplasmic reticulum stress and autophagy modulation after fatty liver graft preservation: a role for melatonin and trimetazidine cocktail.

Zaouali MA, Boncompagni E, Reiter RJ, Bejaoui M, Freitas I, Pantazi E, Folch-Puy E, Abdennebi HB, Garcia-Gil FA, Roselló-Catafau J.

J Pineal Res. 2013 Aug;55(1):65-78. doi: 10.1111/jpi.12051. Epub 2013 Mar 29.

PMID:
23551302
11.

Human C1 inhibitor attenuates liver ischemia-reperfusion injury and promotes liver regeneration.

Saidi RF, Rajeshkumar B, Shariftabrizi A, Dresser K, Walter O.

J Surg Res. 2014 Apr;187(2):660-6. doi: 10.1016/j.jss.2013.09.009. Epub 2013 Oct 2.

PMID:
24433870
12.

Losartan activates sirtuin 1 in rat reduced-size orthotopic liver transplantation.

Pantazi E, Bejaoui M, Zaouali MA, Folch-Puy E, Pinto Rolo A, Panisello A, Palmeira CM, Roselló-Catafau J.

World J Gastroenterol. 2015 Jul 14;21(26):8021-31. doi: 10.3748/wjg.v21.i26.8021.

13.

Proteasome inhibitor up regulates liver antioxidative enzymes in rat model of alcoholic liver disease.

Bardag-Gorce F, Oliva J, Lin A, Li J, French BA, French SW.

Exp Mol Pathol. 2011 Feb;90(1):123-30. doi: 10.1016/j.yexmp.2010.10.013. Epub 2010 Oct 29.

14.

IGL-1 solution reduces endoplasmic reticulum stress and apoptosis in rat liver transplantation.

Mosbah IB, Zaouali MA, Martel C, Bjaoui M, Abdennebi HB, Hotter G, Brenner C, Roselló-Catafau J.

Cell Death Dis. 2012 Mar 8;3:e279. doi: 10.1038/cddis.2012.12.

15.

Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury.

Coito AJ, Buelow R, Shen XD, Amersi F, Moore C, Volk HD, Busuttil RW, Kupiec-Weglinski JW.

Transplantation. 2002 Jul 15;74(1):96-102.

PMID:
12134106
16.

Proteasome inhibitor treatment in alcoholic liver disease.

Bardag-Gorce F.

World J Gastroenterol. 2011 May 28;17(20):2558-62. doi: 10.3748/wjg.v17.i20.2558.

17.

FK330, a novel inducible nitric oxide synthase inhibitor, prevents ischemia and reperfusion injury in rat liver transplantation.

Tsuchihashi S, Kaldas F, Chida N, Sudo Y, Tamura K, Zhai Y, Qiao B, Busuttil RW, Kupiec-Weglinski JW.

Am J Transplant. 2006 Sep;6(9):2013-22. Epub 2006 Jun 22.

18.
19.

IL-10 increases tissue injury after selective intestinal ischemia/reperfusion.

Nüssler NC, Müller AR, Weidenbach H, Vergopoulos A, Platz KP, Volk HD, Neuhaus P, Nussler AK.

Ann Surg. 2003 Jul;238(1):49-58.

20.

Bortezomib enhances fatty liver preservation in Institut George Lopez-1 solution through adenosine monophosphate activated protein kinase and Akt/mTOR pathways.

Bejaoui M, Zaouali MA, Folch-Puy E, Pantazi E, Bardag-Gorce F, Carbonell T, Oliva J, Rimola A, Abdennebi HB, Roselló-Catafau J.

J Pharm Pharmacol. 2014 Jan;66(1):62-72. doi: 10.1111/jphp.12154. Epub 2013 Oct 16.

PMID:
24127984

Supplemental Content

Support Center